Showing results (471-480 of 499) with videos related to
Sort By:
Pageof 50
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2025
The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH TrialIseult M Browne, Javier Pascual, Rosalind J Cutts, et al.Journal of the American College of Cardiology|October 20, 2018
Effect of Evolocumab on Coronary Plaque CompositionStephen J Nicholls, Rishi Puri, Todd Anderson, et al.Nature Communications|June 10, 2022
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancerR C Coombes, P D Badman, J P Lozano-Kuehne, et al.European Heart Journal|November 10, 2000
Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 InvestigatorsE M Antman, C M Gibson, J A de Lemos, et al.Journal of the National Cancer Institute|May 1, 2016
Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the OthersJohn M S Bartlett, Jane Bayani, Andrea Marshall, et al.Nature Communications|December 1, 2018
Mutant p53s generate pro-invasive niches by influencing exosome podocalyxin levelsDavid Novo, Nikki Heath, Louise Mitchell, et al.Kidney360|April 4, 2022
Long-Term Impact of Arteriovenous Fistula Ligation on Cardiac Structure and Function in Kidney Transplant Recipients: A 5-Year Follow-Up Observational Cohort StudyTania Salehi, Nicholas J Montarello, Nishant Juneja, et al.JAMA Cardiology|July 27, 2018
Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical TrialStephen J Nicholls, Jordan Andrews, John J P Kastelein, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2023
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)Alistair Ring, Lucy S Kilburn, Alex Pearson, et al.American Journal of Preventive Cardiology|July 30, 2021
Tackling cardiometabolic risk in the Asia Pacific regionJian-Jun Li, Khung Keong Yeo, Kathyrn Tan, et al.Pageof 50